An experimental new mRNA vaccine for cancer is being tested on British patients.
Known as mRNA therapy, the new cancer treatment from Moderna has been administered to patients at Hammersmith hospital in west London.
The trial aims to evaluate the therapy's safety and effectiveness in treating melanoma, lung cancer and other solid tumours.
"New mRNA-based cancer immunotherapies offer an avenue for recruiting the patient's own immune system to fight their cancer," said Dr David Pinato of Imperial College London, an investigator with the trial's UK arm.
A number of cancer vaccines have recently entered clinical trials across the globe.
These fall into two categories: personalised cancer immunotherapies, which rely on extracting a patient's own genetic material from their tumours; and therapeutic cancer immunotherapies, such as the mRNA therapy newly launched in London, which are "Ready made" and tailored to a particular type of cancer.
The primary aim of the new trial - known as Mobilize - is to discover if this particular type of mRNA therapy is safe and tolerated by patients with lung or skin cancers and can shrink tumours.
https://thepeoplesvoice.tv/modernas-new-mrna-cancer-vaccine-trialled-on-patients-in-uk/
No comments:
Post a Comment